The unique multitenant cloud capabilities of Veeva Vault enable Daiichi Sankyo to easily streamline management of its critical content, providing external partners, such as CROs, the same level of secure access and collaboration as internal operations teams.
Another key benefit was the ability of Veeva’s support organization to implement Veeva Vault in a short period of time to drive greater consistency globally at every stage of product development, from clinical to quality to regulatory.
“Veeva Vault was superior to every solution we evaluated in the market,” said Yasuhiro Ikeda, the Vice President, IT Strategy Department.
“Veeva gives us a true cloud platform to stay current on the latest technology capabilities. With Veeva conducting installation qualification (IQ) and operational qualification (OQ) processes, we expect to save resources and costs not having to upgrade projects every several years. Lastly, Veeva provided a sandbox environment during our selection phase for users to test technical and business capabilities. The high satisfaction among our users was one of the deciding factors in selecting Veeva.”
“Veeva Vault makes it easier for pharmaceutical companies based in Japan to accelerate their global efforts,” said Takashi Okamura, general manager of Veeva Japan.
“We are honored to globally support Daiichi Sankyo and deliver greater visibility, transparency, and efficiency in their global pharmaceutical operations.”